//
Double trouble as GW faces US legal action and widening lossesImpending legal action in the US and widening losses add up to a crunch period for Cambridge UK cannabis-derived life science company GW Pharmaceuticals. |
|
Illumina’s proposed new building at Granta ParkIllumina, which is scaling up its research capability in Cambridge UK, has formed a partnership with Genomics England to develop a platform and knowledge base that can be used to… |
|
Cambridge acquisition target launches Zika virus testA business being acquired by Cambridge UK company Novacyt has launched one of the world’s first test kits for the Zika virus. |
|
Digital Cambridge booming, says new reportCambridge ranks in the top UK hotspots for growth of its digital economy, a new national report published today reveals. The Tech Nation 2016 report by Tech City UK and Nesta shows… |
from Business Weekly http://ift.tt/1o9DDc8